Rainer Voisard

1.2k total citations
45 papers, 713 citations indexed

About

Rainer Voisard is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Rainer Voisard has authored 45 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 13 papers in Molecular Biology and 12 papers in Immunology. Recurrent topics in Rainer Voisard's work include Coronary Interventions and Diagnostics (15 papers), Cell Adhesion Molecules Research (11 papers) and Atherosclerosis and Cardiovascular Diseases (9 papers). Rainer Voisard is often cited by papers focused on Coronary Interventions and Diagnostics (15 papers), Cell Adhesion Molecules Research (11 papers) and Atherosclerosis and Cardiovascular Diseases (9 papers). Rainer Voisard collaborates with scholars based in Germany, United States and France. Rainer Voisard's co-authors include Vinzenz Hombach, Peter C. Dartsch, E. Betz, Gerhard Bauriedel, B. Höfling, Martin Höher, A. Hannekum, Hans H. Osterhues, Torsten Mattfeldt and Matthias Kochs and has published in prestigious journals such as Circulation, The FASEB Journal and Cardiovascular Research.

In The Last Decade

Rainer Voisard

44 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rainer Voisard Germany 17 252 183 179 126 100 45 713
Kurt G. Barringhaus United States 16 228 0.9× 308 1.7× 204 1.1× 131 1.0× 46 0.5× 30 836
Dolf Segers Netherlands 12 175 0.7× 169 0.9× 187 1.0× 170 1.3× 41 0.4× 16 617
Carol Cornejo United States 13 190 0.8× 170 0.9× 64 0.4× 87 0.7× 68 0.7× 17 659
Isabelle Dubus France 15 155 0.6× 290 1.6× 177 1.0× 98 0.8× 36 0.4× 30 844
Mary Drinane United States 11 229 0.9× 408 2.2× 80 0.4× 78 0.6× 99 1.0× 16 861
Rosaly Correa United States 12 423 1.7× 528 2.9× 234 1.3× 102 0.8× 43 0.4× 15 980
Roman Metzger Germany 18 316 1.3× 252 1.4× 135 0.8× 63 0.5× 71 0.7× 58 870
J Dämmrich Germany 16 160 0.6× 448 2.4× 124 0.7× 113 0.9× 56 0.6× 52 1.0k
Wijnand K. den Dekker Netherlands 15 375 1.5× 260 1.4× 247 1.4× 173 1.4× 40 0.4× 73 819
Charles W. Wyble United States 11 207 0.8× 156 0.9× 79 0.4× 226 1.8× 34 0.3× 18 727

Countries citing papers authored by Rainer Voisard

Since Specialization
Citations

This map shows the geographic impact of Rainer Voisard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Voisard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Voisard more than expected).

Fields of papers citing papers by Rainer Voisard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Voisard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Voisard. The network helps show where Rainer Voisard may publish in the future.

Co-authorship network of co-authors of Rainer Voisard

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Voisard. A scholar is included among the top collaborators of Rainer Voisard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Voisard. Rainer Voisard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Voisard, Rainer, et al.. (2007). Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratio's. BMC Cardiovascular Disorders. 7(1). 15–15. 4 indexed citations
3.
Voisard, Rainer, Barbara Reinhardt, Bianca Vaida, et al.. (2007). HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasia. BMC Microbiology. 7(1). 68–68. 6 indexed citations
4.
Voisard, Rainer, et al.. (2006). Edge restenosis: impact of low dose irradiation on cell proliferation and ICAM-1 expression. BMC Cardiovascular Disorders. 6(1). 32–32. 3 indexed citations
5.
Voisard, Rainer, et al.. (2005). Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models. BMC Cardiovascular Disorders. 5(1). 9–9. 6 indexed citations
6.
Voisard, Rainer, A. Stemberger, Ansgar Resch, et al.. (2004). Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound. International Journal of Cardiology. 102(3). 425–433. 6 indexed citations
7.
Reinhardt, Barbara, Bianca Vaida, Rainer Voisard, et al.. (2003). Human cytomegalovirus infection in human renal arteries in vitro. Journal of Virological Methods. 109(1). 1–9. 18 indexed citations
8.
Höher, Martin, Jochen Wöhrle, Hartmut Hanke, et al.. (2000). Intracoronary β-Irradiation With a Liquid 188 Re-Filled Balloon. Circulation. 101(20). 2355–2360. 57 indexed citations
9.
Schaarschmidt, Peter, Barbara Reinhardt, Detlef Michel, et al.. (1999). Altered Expression of Extracellular Matrix in Human-Cytomegalovirus-Infected Cells and a Human Artery Organ Culture Model to Study Its Biological Relevance. Intervirology. 42(5-6). 357–364. 10 indexed citations
10.
Voisard, Rainer. (1999). A human arterial organ culture model of postangioplasty restenosis: results up to 56 days after ballooning. Atherosclerosis. 144(1). 123–134. 24 indexed citations
11.
Voisard, Rainer, Torsten Mattfeldt, Wolfgang Hemmer, et al.. (1998). Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-α. Coronary Artery Disease. 9(11). 737–745. 16 indexed citations
12.
Voisard, Rainer, Stefan Koschnick, Ulrich Vogel, et al.. (1997). High-dose diltiazem prevents migration and prolifera vascular smooth muscle cells in various in-vitro mod human coronary restenosis. Coronary Artery Disease. 8(3/4). 189–204. 13 indexed citations
13.
Voisard, Rainer, et al.. (1997). Ca2+-activated K+ channels in human smooth muscle cells of coronary atherosclerotic plaques and coronary media segments. Basic Research in Cardiology. 92(4). 233–239. 28 indexed citations
14.
Haug, Charlotte, Rainer Voisard, Andreas Lenich, et al.. (1996). Increased endothelin release by cultured human smooth muscle cells from atherosclerotic coronary arteries. Cardiovascular Research. 31(5). 807–813. 14 indexed citations
15.
Voisard, Rainer, et al.. (1995). A prescreening system for potential antiproliferative agents: implications for local treatment strategies of postangioplasty restenosis. International Journal of Cardiology. 51(1). 15–28. 19 indexed citations
16.
Voisard, Rainer, et al.. (1995). A coronary porcine organ culture system for studies of postangioplasty cell proliferation. Coronary Artery Disease. 6(8). 657–666. 12 indexed citations
17.
Voisard, Rainer, et al.. (1994). Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro. International Journal of Cardiology. 43(3). 257–267. 49 indexed citations
18.
19.
Voisard, Rainer, et al.. (1992). [The effect of propranolol, lisinopril, prednisolone, colchicine, etoposide and vincristine on proliferation of re-stenosing human plaque cells in vitro: cell culture as a prescreening system for prevention of restenosis].. PubMed. 35. 128–9.
20.
Voisard, Rainer, et al.. (1991). [Cell culture as a prescreening system for drug prevention of restenosis?].. PubMed. 33(5). 140–1. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kurt G. Barringhaus Breakdown of academic impact, for papers by Dolf Segers Breakdown of academic impact, for papers by Carol Cornejo Breakdown of academic impact, for papers by Isabelle Dubus Breakdown of academic impact, for papers by Mary Drinane Breakdown of academic impact, for papers by Rosaly Correa Breakdown of academic impact, for papers by Roman Metzger Breakdown of academic impact, for papers by J Dämmrich Breakdown of academic impact, for papers by Wijnand K. den Dekker Breakdown of academic impact, for papers by Charles W. Wyble
Rankless by CCL
2026